Biogen Inc. company logo
Biogen Inc. logo

Biogen Inc. (BIIB) Depreciation & Amortization

Annual D&A

$673.20M$178.40M+36.05%

Summary

Current Value
As of today, BIIB annual D&A is $673.20M, up +36.05% on
Historical Performance
BIIB annual D&A is up +38.04% over the past 3 years, with unknown 5-year change
All-Time High Comparison
BIIB annual D&A is currently -6.71% below its historical high of $721.60M set on
3-Year Low Comparison
BIIB annual D&A is +36.05% above its 3-year low of $494.80M reached on
Sector Comparison
BIIB annual D&A is higher than 96.25% of companies in Healthcare sector

Depreciation & Amortization Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

BIIB Performance
MetricDateValue1Y3Y5Y15Y
Annual D&A$673.20M+36.0%+38.0%+57.3%
Quarterly D&A$202.20M+10.6%+67.5%+76.3%+124.3%
TTM D&A$763.70M+21.4%+43.2%+212.3%+116.2%
Price$172.62+22.4%-39.6%-36.1%+158.5%
Annual SG&A$2.40B-5.7%-10.1%+1.2%+113.3%
Annual Total Expenses$7.46B-6.8%-8.8%+1.6%+142.0%
Annual Operating Expenses$5.15B-5.9%-15.1%-4.5%+90.6%
Annual Revenue$9.27B-1.6%-10.9%+153.6%

Depreciation & Amortization Highs

BIIB Annual D&A Highs Comparison
PeriodHighDateCurrent
3Y$673.20Mat high
5Y$673.20Mat high
All$721.60M-6.7%

Depreciation & Amortization Lows

BIIB Annual D&A Lows Comparison
PeriodLowDateCurrent
3Y$494.80M+36.0%
5Y$457.20MN/A+47.2%
All-$3.80M>+9999.0%

Depreciation & Amortization History

YearValueChange
$673.20M+36.1%
$494.80M-4.6%
$518.40M+6.3%
$487.70M+6.7%
$457.20M-29.7%
$650.60M-9.8%
$721.60M+5.7%
$682.70M+13.7%
$600.40M-5.8%
$637.25M+19.8%
$531.74M+45.4%
$365.65M+1.9%
$358.93M+1.4%
$354.10M-17.3%
$427.96M-7.4%
$462.06M+21.5%
$380.29M-5.4%
YearValueChange
$402.21M-8.5%
$439.44M+616.8%
$61.31M+503.7%
$10.16M+61.1%
$6.31M+33.1%
$4.74M+8.5%
$4.37M+8.9%
$4.01M+51.7%
$2.64M+10.1%
$2.40M-0.9%
$2.42M+238.3%
$716.00K+39.6%
$513.00K+6.6%
$481.20K+112.7%
-$3.80M-15.2%
-$3.30M-

FAQ

  • What is the current annual D&A of BIIB?

    As of today, BIIB annual D&A is $673.20M

  • What is 1-year change in BIIB annual D&A?

    BIIB annual D&A is up +36.05% year-over-year

  • What is 3-year change in BIIB annual D&A?

    BIIB annual D&A is up +38.04% over the past 3 years

  • How far is BIIB annual D&A from its all-time high?

    BIIB annual D&A is currently -6.71% below its historical high of $721.60M set on December 31, 2017

  • How does BIIB annual D&A rank versus sector peers?

    BIIB annual D&A is higher than 96.25% of companies in Healthcare sector

  • When is BIIB next annual earnings release?

    The next annual earnings release for BIIB is on

Data Sources & References

  1. BIIB Official Website www.biogen.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/875045/000087504525000049/0000875045-25-000049-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875045/000087504525000009/0000875045-25-000009-index.htm
  4. BIIB Profile on Yahoo Finance finance.yahoo.com/quote/BIIB
  5. BIIB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/biib